Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
J Ren Nutr. 2012 Jul;22(4):400-8. doi: 10.1053/j.jrn.2011.08.007. Epub 2011 Nov 9.
To determine vitamin D status in a subtropical climate among an unselected, referred predialysis chronic kidney disease (CKD) population; assess risks and correlates; and review whether higher 25-hydroxyvitamin D (25-OHD) concentration can mitigate the decrement in circulating 1,25-dihydroxyvitamin D (1,25-OHD) normally encountered with advancing CKD.
Prospective cross-sectional cohort study.
Renal unit in Brisbane, Australia (27°28' S).
Five hundred ninety-three consecutive CKD patients (stage 1 to 5).
25-OHD insufficiency (concentrations: 15 to 30 ng/mL) and deficiency (<15 ng/mL), bone-mineral parameters, including 1,25-OHD, calcium, and phosphate.
Despite potentially higher environmental ultraviolet (UV) exposure, only 48% of patients with CKD were 25-OHD sufficient. Traditional risks for hypovitaminosis D were maintained, and sufficiency was independently predicted by testing in the summer/autumn period (odds ratio [OR]: 2.77, 95% confidence interval [CI]: 1.88 to 4.08, P < .001), male gender (OR: 2.18, 95%CI: 1.46 to 3.24, P < .001), Caucasian race (OR: 2.28, 95%CI: 1.37 to 3.78, P = .001), hypoalbuminemia (OR: 0.47, 95%CI: 0.25 to 0.85, P = .01), macroalbuminuria (OR: 0.60, 95%CI: 0.39 to 0.92, P = .02), and normal body mass index (OR: 1.94, 95%CI: 1.22 to 3.07, P = .005). Vitamin D sufficiency was also associated with higher corrected calcium (0.4 mg/dL increments; OR: 1.29, 95%CI: 1.08 to 1.55, P = .005). Although circulating 25-OHD concentrations were relatively maintained across the range of renal function observed, 1,25-OHD concentrations decreased with advancing CKD.
25-OHD insufficiency is mitigated but still highly prevalent in patients with CKD in a high ambient UV environment. Despite the maintenance of relatively higher 25-OHD concentrations with advancing CKD, substrate availability does not appear to be a major determinant of circulating 1,25-OHD.
在亚热带气候中,对未经选择的、透析前慢性肾脏病(CKD)人群进行维生素 D 状态评估;评估风险和相关性;并回顾较高的 25-羟维生素 D(25-OHD)浓度是否可以减轻随着 CKD 进展而正常出现的循环 1,25-二羟维生素 D(1,25-OHD)浓度降低。
前瞻性横断面队列研究。
澳大利亚布里斯班的肾脏科(南纬 27°28')。
593 例连续 CKD 患者(分期 1 至 5 期)。
25-OHD 不足(浓度:15 至 30ng/mL)和缺乏(<15ng/mL)、骨矿物质参数,包括 1,25-OHD、钙和磷酸盐。
尽管环境中紫外线(UV)暴露可能更高,但只有 48%的 CKD 患者 25-OHD 充足。维生素 D 缺乏的传统风险仍然存在,并且在夏季/秋季进行检测可独立预测充足(优势比[OR]:2.77,95%置信区间[CI]:1.88 至 4.08,P<0.001)、男性(OR:2.18,95%CI:1.46 至 3.24,P<0.001)、白种人(OR:2.28,95%CI:1.37 至 3.78,P=0.001)、低白蛋白血症(OR:0.47,95%CI:0.25 至 0.85,P=0.01)、大量蛋白尿(OR:0.60,95%CI:0.39 至 0.92,P=0.02)和正常体重指数(OR:1.94,95%CI:1.22 至 3.07,P=0.005)。维生素 D 充足也与校正钙增加相关(0.4mg/dL 增量;OR:1.29,95%CI:1.08 至 1.55,P=0.005)。尽管随着观察到的肾功能范围的变化,循环 25-OHD 浓度相对保持,但随着 CKD 的进展,1,25-OHD 浓度下降。
在高环境 UV 环境中,CKD 患者的 25-OHD 不足得到缓解但仍高度流行。尽管随着 CKD 的进展,相对较高的 25-OHD 浓度保持,但底物可用性似乎不是循环 1,25-OHD 的主要决定因素。